Head-to-head · Cost-Efficiency Index
Teladoc Health vs Cabana
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Teladoc Health
Patients whose employer or insurance plan already includes Teladoc Health's GLP-1 program -- not a fit for cash-pay shoppers comparing prices.
Visit Teladoc HealthCabana
Shoppers who want a lifestyle-branded concierge wellness experience bundling GLP-1 with other treatments.
Visit CabanaThe verdict
Teladoc Health takes it, leading the Cost-Efficiency Index 41 to 40. Teladoc Health is the large, publicly traded telehealth company; its GLP-1 program is only accessible through an employer- or insurance-sponsored plan. Cabana still earns a C — Shoppers who want a lifestyle-branded concierge wellness experience bundling GLP-1 with other treatments.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Teladoc Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Teladoc Health | Cabana |
|---|---|---|
| Cost-Efficiency Index | 41/100 | 40/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #522 | #525 |
Teladoc Health
41/100Where the value is
- Backed by a large, publicly traded, well-established telehealth infrastructure
- GLP-1 program integrated into a broader virtual weight-management and primary-care offering
- Self-pay fallback is mentioned as theoretically available if insurance doesn't cover the drug
The tradeoffs
- No direct-to-consumer cash-pay pricing published anywhere -- access requires an employer/insurance sponsor
- Not usable by an individual cash-pay shopper simply comparing GLP-1 prices online
Cabana
40/100Where the value is
- Offers a semaglutide tablet option in addition to injectables
- Single, findable headline price ($249/mo starting) visible without an account
- Explicit disclaimer distinguishing FDA-approved vs. compounded (non-FDA-approved) medications
The tradeoffs
- Pricing is not broken out by specific drug or dose -- unclear what a semaglutide vs. tirzepatide patient actually pays
- 'Starting At' framing with no clarification of whether $249 is promotional or standard
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.